Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread

Kristen A Batich1,2,3, Richard F Riedel2,4, John P Kirkpatrick3,4,5,6

  • 1Department of Medicine, Duke University Health System, Durham, NC, United States.

Frontiers in Oncology
|December 19, 2019
PubMed

Insights

Extradural myxopapillary ependymomas, rare tumors, can spread to distant sites like the lungs. This case highlights the need for further research into treating these rare tumors and their metastases.

Area of Science:

  • Neuro-oncology
  • Spinal cord tumors

Background:

  • Myxopapillary ependymomas are typically slow-growing, Grade I glial tumors found in the lumbosacral region.
  • Extradural and subcutaneous sacrococcygeal or perisacral presentations are rare but associated with a higher risk of spread.

Observation:

  • A patient presented with a sacrococcygeal mass confirmed as extradural myxopapillary ependymoma.
  • Pulmonary nodules were detected at initial resection and increased in size with tumor recurrence at the resection site two years later.
  • Recurrent tumor with oligometastatic spread to the lungs was confirmed.

Findings:

  • This case demonstrates extradural myxopapillary ependymoma recurrence with oligometastatic spread.
  • Current treatment involves maximal surgical resection, with or without radiotherapy, but lacks definitive guidelines for extradural or metastatic disease.
  • Evidence is insufficient regarding the benefit of radiotherapy for oligometastatic foci in extending survival or time to recurrence.

Implications:

  • Definitive therapeutic guidelines for extradural myxopapillary ependymoma and its metastases are lacking due to rarity.
  • Prospective studies are needed to evaluate the efficacy of upfront treatment for oligometastases, including local resection and adjuvant radiotherapy.
  • Improved understanding of extradural myxopapillary ependymoma management is crucial for better patient outcomes.